Recruitment

Recruitment Status
Active, not recruiting
Estimated Enrollment
Same as current

Summary

Conditions
  • Energy Expenditure
  • Glucose Metabolism
  • Safety Issues
Type
Interventional
Phase
Not Applicable
Design
Allocation: N/AIntervention Model: Single Group AssignmentIntervention Model Description: Case study in a single human subjectMasking: None (Open Label)Primary Purpose: Other

Participation Requirements

Age
Between 18 years and 70 years
Gender
Both males and females

Description

The subject will be treated for 8 weeks with the combination of naringenin + beta carotene. We will conduct the following assessments before the treatment and at the end of eight weeks. Resting metabolic rate Oral glucose tolerance test with glucose and insulin Ambulatory blood pressure Recording of...

The subject will be treated for 8 weeks with the combination of naringenin + beta carotene. We will conduct the following assessments before the treatment and at the end of eight weeks. Resting metabolic rate Oral glucose tolerance test with glucose and insulin Ambulatory blood pressure Recording of adverse events

Tracking Information

NCT #
NCT04697355
Collaborators
Not Provided
Investigators
Principal Investigator: Frank L Greenway, M.D. Pennington Biomedical Research Center